Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway is a research paper published in PLOS ONE (2019). On theSindex it has a DataRank of 0.550. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Astellas Pharma US
Grant: ENZA-15C03
Vanderbilt University Medical Center
Grant: 5K12CA090625-18
Vanderbilt Clinical Oncology Research Career Development Award
NIDDK NIH HHS
Grant: U24 DK059637
NIDDK NIH HHS
Grant: P30 DK058404
NCI NIH HHS
Grant: K12 CA090625
NIH HHS
Grant: S10 OD023475
NCI NIH HHS
Grant: P30 CA068485
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3P30CA068485-21S4
Cancer Center Support Grant
National Institutes of Health
Grant: 5U24DK059637-13
Vanderbilt Mouse Metabolic Phenotyping Center
FWCI
3.48
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals